MIRUM PHARMACEUTICALS, INC.

(MIRM)
  Report
Delayed Nasdaq  -  05/20 04:00:01 pm EDT
25.58 USD   +5.66%
05/18Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
BU
05/10Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
05/05MIRUM PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart MIRUM PHARMACEUTICALS, INC.
Upcoming events on MIRUM PHARMACEUTICALS, INC.
06/02/22 Annual General Meeting
08/31/22 Interim 2022 Earnings Release (Projected)
11/16/22 Q3 2022 Earnings Release (Projected)
03/08/23 FY 2022 Earnings Release (Projected)
05/04/23 Q1 2023 Earnings Release (Projected)
Past events on MIRUM PHARMACEUTICALS, INC.
05/05/22 | 08:30am Q1 2022 Earnings Call
05/05/22 | 08:00am Q1 2022 Earnings Release
03/09/22 | 04:30pm FY 2021 Earnings Call
03/09/22 | 04:00pm FY 2021 Earnings Release
02/16/22 | 04:20pm SVB Leerink Global Healthcare Conference
01/11/22 | 01:30pm JP Morgan Healthcare Conference
01/10/22 | 07:00am H.C. Wainwright BioConnect Conference
12/17/21 | 01:30pm North American Society for Pediatric Gastroenterology Hepatology and Nutrition Meeting - Abstract No
12/17/21 | 01:30pm North American Society for Pediatric Gastroenterology Hepatology and Nutrition Meeting - Abstract No
12/15/21 | 01:30pm North American Society for Pediatric Gastroenterology Hepatology and Nutrition Meeting - Abstract No
Past dividends on MIRUM PHARMACEUTICALS, INC.

- No events available -

Annual results
Fiscal Period : December20182019202020212022
Sales
M $
Released
Forecast
Spread


 


 

8,33
 
19,1
78,4
-76%
 
72,1
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 


 


 
-173
-169
-2,3%
 
-124
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-17,4

 
-54,7
-53,1
-3,0%
-104
-91,8
-14%
-173
-141
-23%
 
-149
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread


 
-52,5
-51,7
-1,6%
-103
-90,1
-15%
-84,0
-137
39%
 
-154
 
Net income
M $
Released
Forecast
Spread
-17,3

 
-52,6
-51,7
-1,7%
-103
-90,1
-15%
-84,0
-129
35%
 
-154
 
EPS
$
Released
Forecast
Spread


 
-4,58
-3,68
-24%
-4,09
-3,57
-14%
-2,77
-4,51
39%
 
-4,44
 
Announcement Date04/18/201903/12/202003/09/202103/09/2022-
Quarterly results
Fiscal Period : December2021 Q12021 Q22021 Q32021 Q42022 Q12022 Q2
Sales
M $
Released
Forecast
Spread

8,33
 
11,0
1,84
499%
5,00

 
3,14
62,7
-95%
12,9
8,46
52%
 
15,9
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 


 
-42,7
-46,0
7,1%
-45,2
-41,0
-10%
-32,4
-36,0
10%
 
-25,0
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-47,6
-29,0
-64%
-37,4
-30,1
-24%
-42,8
-55,9
23%
-45,6
-13,1
-247%
-32,7
-43,6
25%
 
-36,5
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-50,5
-30,5
-66%
-43,9
-27,2
-61%
-47,1
-57,5
18%
57,6
4,37
1 218%
-36,6
-45,8
20%
 
-38,2
 
Net income
M $
Released
Forecast
Spread
-50,5
-30,5
-66%
-43,9
-27,2
-61%
-47,1
-57,5
18%
57,5
13,1
339%
-36,6
-43,6
16%
 
-37,7
 
EPS
$
Released
Forecast
Spread
-1,68
-1,04
-62%
-1,45
-0,46
-217%
-1,55
-1,89
18%
1,91
0,30
529%
-1,17
-1,40
16%
 
-1,20
 
Announcement Date05/06/202108/05/202111/15/202103/09/202205/05/2022-
Previous year Next Year
Upcoming sector events for MIRUM PHARMACEUTICALS, INC.
More events
Past sector events for MIRUM PHARMACEUTICALS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise